JP2024519819A5 - - Google Patents
Info
- Publication number
- JP2024519819A5 JP2024519819A5 JP2023571323A JP2023571323A JP2024519819A5 JP 2024519819 A5 JP2024519819 A5 JP 2024519819A5 JP 2023571323 A JP2023571323 A JP 2023571323A JP 2023571323 A JP2023571323 A JP 2023571323A JP 2024519819 A5 JP2024519819 A5 JP 2024519819A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- aav
- use according
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163189836P | 2021-05-18 | 2021-05-18 | |
| US63/189,836 | 2021-05-18 | ||
| US202163275527P | 2021-11-04 | 2021-11-04 | |
| US63/275,527 | 2021-11-04 | ||
| US202263334949P | 2022-04-26 | 2022-04-26 | |
| US63/334,949 | 2022-04-26 | ||
| PCT/US2022/029797 WO2022245919A1 (en) | 2021-05-18 | 2022-05-18 | Methods and compositions for treating ocular diseases and disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519819A JP2024519819A (ja) | 2024-05-21 |
| JP2024519819A5 true JP2024519819A5 (cg-RX-API-DMAC7.html) | 2025-05-26 |
Family
ID=84140790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571323A Pending JP2024519819A (ja) | 2021-05-18 | 2022-05-18 | 眼疾患および障害を処置するための方法および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240269326A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4340856A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024519819A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3216533A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022245919A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021009913A2 (pt) | 2018-12-05 | 2021-08-17 | Abeona Therapeutics, Inc. | vetor viral adeno-associado recombinante para inserção gênica |
| AU2024294136A1 (en) * | 2023-07-20 | 2026-02-05 | Children's Medical Research Institute | Modified cardiotropic aav capsid polypeptides and vectors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3012344A1 (en) * | 2016-02-12 | 2017-08-17 | University Of Massachusetts | Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization |
| WO2020018766A1 (en) * | 2018-07-20 | 2020-01-23 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Intraocular delivery of gene therapy expression vectors |
| BR112021009913A2 (pt) * | 2018-12-05 | 2021-08-17 | Abeona Therapeutics, Inc. | vetor viral adeno-associado recombinante para inserção gênica |
-
2022
- 2022-05-18 EP EP22805383.1A patent/EP4340856A4/en active Pending
- 2022-05-18 WO PCT/US2022/029797 patent/WO2022245919A1/en not_active Ceased
- 2022-05-18 JP JP2023571323A patent/JP2024519819A/ja active Pending
- 2022-05-18 US US18/561,784 patent/US20240269326A1/en active Pending
- 2022-05-18 CA CA3216533A patent/CA3216533A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220387560A1 (en) | Adeno-Associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease | |
| JP2022515338A5 (cg-RX-API-DMAC7.html) | ||
| WO2023284879A1 (en) | Modified aav capsid for gene therapy and methods thereof | |
| CN111819281B (zh) | 用于神经变性疾病的基因疗法 | |
| EP2661494B1 (en) | Promoters, expression cassettes and vectors for use treating achromatopsia and other diseases | |
| JP2024519888A5 (cg-RX-API-DMAC7.html) | ||
| JP2022531861A5 (cg-RX-API-DMAC7.html) | ||
| JP2023535956A5 (cg-RX-API-DMAC7.html) | ||
| JP2022516317A5 (cg-RX-API-DMAC7.html) | ||
| US20250213722A1 (en) | Adeno-associated virus vectors for nucleic acid delivery to retinal ganglion cells and/or retinal pigment epithelium cells | |
| AU2017222948B2 (en) | Gene therapy for the treatment of a disease of retinal cone cells | |
| AU2017222231B2 (en) | Gene therapy for the treatment of a retinal degeneration disease | |
| US20250327092A1 (en) | Adeno-associated virus vectors for nucleic acid delivery to retinal cells | |
| JP2025503910A5 (cg-RX-API-DMAC7.html) | ||
| JP2024519819A (ja) | 眼疾患および障害を処置するための方法および組成物 | |
| JP2023551254A5 (cg-RX-API-DMAC7.html) | ||
| US20250222135A1 (en) | Adeno-associated virus vectors for nucleic acid delivery across retinal regions | |
| JP2022523050A5 (cg-RX-API-DMAC7.html) | ||
| CN113347962A (zh) | 通过合理设计增强的新型aav病毒在视网膜中的高效转导和侧向扩散 | |
| US20260042803A1 (en) | Variant aav capsid polypeptides targeting the eye | |
| TW202615665A (zh) | 腺相關病毒載體 | |
| WO2026039585A2 (en) | Adeno-associated virus vectors | |
| WO2025231336A1 (en) | Adeno-associated virus vectors | |
| WO2024110770A1 (en) | A new promoter for retinal pigment epithelium (rpe) targeted gene therapy | |
| WO2025072698A2 (en) | Aav9 vectors and capsid polypeptides for use in treating cns disorders |